Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. Advances in Insulin Pump Infusion Sets Symposium Report

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Feasibility of a New Approach to Initiate Insulin in Type 2 Diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

Hypoglycemia can lead to seizures, unconsciousness, or death. Insulin pump treatment reduces the frequency of severe hypoglycemia compared with multiple daily injections treatment. The addition of a continuous glucose monitor, so-called sensor-augmented pump (SAP) treatment, has the potential to further limit the duration and severity of hypoglycemia as the system can detect and in some systems act on impending and prevailing low blood glucose levels. In this narrative review we summarize the available knowledge on SAPs with and without automated insulin suspension, in relation to hypoglycemia prevention. We present evidence from randomized trials, observational studies, and meta-analyses including nonpregnant individuals with type 1 diabetes mellitus. We also outline concerns regarding SAPs with and without automated insulin suspension. There is evidence that SAP treatment reduces episodes of moderate and severe hypoglycemia compared with multiple daily injections plus self-monitoring of blood glucose. There is some evidence that SAPs both with and without automated suspension reduces the frequency of severe hypoglycemic events compared with insulin pumps without continuous glucose monitoring.

OriginalsprogEngelsk
TidsskriftJournal of diabetes science and technology
Vol/bind11
Udgave nummer1
Sider (fra-til)50-58
ISSN1932-2968
DOI
StatusUdgivet - 1 jan. 2017

ID: 50079484